Antidepressant nonadherence and sexual dysfunction among young adult males: the cross-sectional YAMAN study
- 6 May 2024
- journal article
- research article
- Published by Springer Nature in World Journal of Urology
- Vol. 42 (1) , 1-7
Abstract
Purpose Selective serotonin reuptake inhibitors are associated with high rates of nonadherence and sexual dysfunction, yet the correlation between these findings in young adult men is poorly characterized. We aimed to evaluate if young adult men are less willing to adhere to antidepressant treatment due to intolerable side effects, such as sexual dysfunction. Methods Deidentified, compensated survey that assessed baseline demographics, PHQ-8 and GAD-7 scores, attitudes towards antidepressant medication side effects, and perceptions of antidepressant medications including selective serotonin reuptake inhibitors, bupropion, and mirtazapine. Results From 665 delivered surveys, 505 respondents completed their survey (response rate: 76%), of which 486 were included for final analysis. After seeing common side effect profiles, our sample’s willingness to take sexual function-sparing agents, such as bupropion or mirtazapine, was significantly greater than selective serotonin reuptake inhibitors (p < 0.001), with no significant difference between bupropion and mirtazapine (p = 0.263). The negative influence of erectile dysfunction and anorgasmia scored significantly higher than other common antidepressant side effects like weight gain, nausea, and dry mouth (range: p < 0.001, p = 0.043). With the exception of insomnia, participants indicated that experiencing sexual dysfunction while taking an antidepressant medication would lead to nonadherence at a significantly higher frequency than any other side effect assessed (range: p < 0.001, p = 0.005). Conclusion The risk of experiencing sexual side effects when taking antidepressants could lead young adult men to become nonadherent to these medications. Strategies to augment the effectiveness of antidepressants, such as shared decision-making and the use of sexual function-sparing agents, are critical.Keywords
Funding Information
- Sexual Medicine Society of North America (Scholars In Sexuality Research Grant)
This publication has 24 references indexed in Scilit:
- Stahl's Essential Psychopharmacology2021
- A growing need for youth mental health services in Canada: examining trends in youth mental health from 2011 to 2018Epidemiology and Psychiatric Sciences, 2020
- Prevalence and Incidence of Anxiety and Depression Among Children, Adolescents, and Young Adults With Life-Limiting ConditionsJAMA Pediatrics, 2019
- The role of masculinity in men's help-seeking for depression: A systematic reviewClinical Psychology Review, 2016
- Antidepressant-Induced Female Sexual DysfunctionMayo Clinic Proceedings, 2016
- Canadian Network for Mood and Anxiety Treatments (CANMAT) Clinical guidelines for the management of major depressive disorder in adults.Journal of Affective Disorders, 2009
- Treatment-Emergent Sexual Dysfunction Related to AntidepressantsJournal of Clinical Psychopharmacology, 2009
- The PHQ-8 as a measure of current depression in the general populationJournal of Affective Disorders, 2009
- Methods for Evaluating Patient Adherence to Antidepressant TherapyMedical Care, 2006
- Safety profile of sustained-release bupropion in depression: Results of three clinical trialsClinical Therapeutics, 1999